Bishnu P De

Title: Innovations of Bishnu P De in Nicotine Addiction Treatment

Introduction

Bishnu P De is a notable inventor based in New Hyde Park, NY (US). He has made significant contributions to the field of nicotine addiction treatment, holding a total of 3 patents. His work focuses on innovative approaches to combat nicotine dependence through immunological methods.

Latest Patents

One of his latest patents is titled "AAV-directed persistent expression of an anti-nicotine antibody gene for smoking cessation." This invention involves an adeno-associated virus (AAV) vector that contains a nucleic acid sequence encoding an antibody or antigen binding fragment that specifically binds to nicotine or its analogs. The patent also describes a composition that includes the AAV vector and methods for using it to induce an immune response against nicotine in mammals.

Another significant patent is the "Development of a highly efficient second generation nicotine-conjugate vaccine to treat nicotine addiction." This invention features a conjugate that comprises an isolated adenovirus hexon protein coupled to nicotine or a nicotine analog. It also outlines a method for inducing an immune response against nicotine in humans using this conjugate.

Career Highlights

Bishnu P De is affiliated with Cornell University, where he continues to advance research in the field of nicotine addiction. His innovative work has the potential to significantly impact public health by providing new avenues for smoking cessation.

Collaborations

He has collaborated with esteemed colleagues such as Ronald G Crystal and Martin J Hicks, contributing to the advancement of research in nicotine addiction and immunotherapy.

Conclusion

Bishnu P De's innovative patents and research efforts represent a significant step forward in the treatment of nicotine addiction. His work not only showcases his expertise but also holds promise for improving the lives of individuals struggling with nicotine dependence.